A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients-Reference-Cited by-同舟云学术

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients

Published:2016-07 Issue:4 Volume:15 Page:495-502
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Flume Patrick A.,VanDevanter Donald R.,Morgan Elizabeth E.,Dudley Michael N.,Loutit Jeffery S.,Bell Scott C.,Kerem Eitan,Fischer Rainald,Smyth Alan R.,Aaron Shawn D.,Conrad Douglas,Geller David E.,Elborn J. Stuart

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference23 articles.

1. Pathophysiology and management of pulmonary infections in cystic fibrosis;Gibson;Am J Respir Crit Care Med,2003

2. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis;Hoiby;Scand J Respir Dis,1977

3. Predictors of mortality in adults with cystic fibrosis;Courtney;Pediatr Pulmonol,2007

4. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry;Kerem;Eur Respir J,2014

5. Treatment of lung infection in patients with cystic fibrosis: current and future strategies;Doring;J Cyst Fibros,2012

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route;Journal of Infection;2024-08

2. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis;Infectious Disease Clinics of North America;2024-03

3. ERS International Congress 2023: highlights from the Respiratory Infections Assembly;ERJ Open Research;2023-11-30

4. Advances in the Cystic Fibrosis Drug Development Pipeline;Life;2023-08-30

5. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis;Cochrane Database of Systematic Reviews;2023-06-02